发明名称 APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES
摘要 The present invention relates to a pharmaceutical composition comprising at least one mRNA comprising at least one coding region for at least one antigen from a tumour, in combination with an aqueous solvent and preferably a cytokine, e.g. GM-CSF, and a process for the preparation of the pharmaceutical composition. The pharmaceutical composition according to the invention is used in particular for therapy and/or prophylaxis against cancer.
申请公布号 US2016089424(A1) 申请公布日期 2016.03.31
申请号 US201514965340 申请日期 2015.12.10
申请人 CureVac AG 发明人 HOERR Ingmar;VON DER MÜLBE Florian;PASCOLO Steve
分类号 A61K39/00 主分类号 A61K39/00
代理机构 代理人
主权项 1. A method of stimulating an antitumor immune response in a subject comprising administering an effective amount of a cell-free composition comprising mRNA encoding an PSA antigen to a subject in need thereof, thereby stimulating a T-cell mediated cytotoxic anticancer immune response in the subject.
地址 Tübingen DE